Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +86-551-65418695
Tel: 0086-551-65418671
Tel: 0086-551-67199489
Tel: 0551-65418672
Tel: +86 551 6541 8675
Tel: +86-551-65418676
Tel: 0551-65418684
Tel: 0086-551 65418681
Tel: 055165418684
Tel: 0086-551-65418684
Tel: 0086 551-67199490
Mobile: 0086-551-18225849144
Tel: +86-551-65418695
Fax: +86-51-65418697
Province/state: Anhui
City: Hefei
Street: B911 Xincheng Business Center, Qianshan Road, Hefei Anhui China
MaxCard:
CAS NO.55297-96-6
Product description
Product Name: Tiamulin fumarate
CAS: 55297-96-6
MF: C32H51NO8S
MW: 609.81
EINECS: 259-581-6
Physical properties
white or white crystalline powder, odourless, tasteless
soluble in methanol or ethanol, dissolved in water, slightly soluble in acetone, almost insoluble in hexane. Melting point 143 ~ 149 ℃. Specific rotation to take this product, accurately weighed, add dioxane dissolved and quantitatively diluted per 1ml solution containing 2mg, specific rotation of + 24 ° to + 27
Specification
Item |
Specification |
Appearance |
White or almost white crystal powder |
Identification |
HPLC: The retention time obtained from the test solution corresponding to that obtained from the standard solution |
IR: IR of the sample corresponding to that reference standard |
|
Color and clarity of solution |
The solution should be clear and colorless, and the absorbance at 400nm and 650nm are not greater than 0.150 and 0.030 |
Specific rotation |
+24~28° |
PH |
3.1~4.1 |
Loss on drying |
≤ 0.5% |
Melting point |
143~149°C |
Fumarate content |
83.7~87.3mg |
Residue on ignition |
≤ 0.1% |
Heavy metals |
≤ 0.001% |
Solvent residue |
≤ 0.5% |
Chromatographic purity |
Any identified impurity ≤ 1.0% |
Any unidentified impurity ≤ 0.5% |
|
Total impurities≤ 2.0% |
|
Assay (on dried basis) |
98.0~102.0% |
DOSAGE
Animal |
Disease |
Tiamulin (ppm) |
Tiamucin庐80 (g/t) |
Administration (Day) |
Withdraw period (Day) |
Swine |
Treatment of pneumonia |
100-200 |
125-250 |
7-10 |
7 |
Prevention of pneumonia |
30-50 |
37.5-62.5 |
Consecutive use in the period of risk |
2 |
|
Treatment of swine dysentery |
100-200 |
125-250 |
7-10 |
7 |
|
Prevention of swine dysentery |
30-50 |
37.5-62.5 |
Consecutive use in the period of risk |
2 |
|
Growth promoter |
10 |
12.5 |
Consecutive use |
0 |
|
Chicken |
Treatment of CRD |
200 |
250 |
3-5 consecutive days |
3 |
Prevention and control of CRD in broilers |
30 |
37.5 |
Consecutive use in the period of risk |
||
Prevention and control of CRD in breeders and layers and improvement in egg production |
50 |
62.5 |
One week per month throughout the laying period |
||
As an aid in the control of CRD in breeders and layers and improvement in egg production and feed conversion efficiency |
20 |
25 |
Consecutive use throughout the laying period |
Application
Antibiotic medicines .for pigs of mycoplasma pneumonia (asthma), mycoplasma arthritis, actinomycetes pleura pneumonia, treponema diarrhea, enteritis, colitis, edema disease, etc.
Packing
25KG/Drum or as per your requirement
Storage
Shading, airtight preservation